| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
|
|---|---|---|---|---|
| Total Revenue
|
150,186.3980 | 119,866.2980 | 98,995.5620 | 91,839.5550 |
|
Cost of Revenue
|
-130,166.1910 | -108,400.0820 | -90,214.6520 | -82,693.0170 |
|
Gross Profit
|
20,020.2070 | 11,466.2160 | 8,780.9100 | 9,146.5380 |
| Selling, General and Administrative Expenses
|
-24,882.8280 | -10,692.4330 | -5,841.7470 | -5,891.1880 |
| Depreciation, Amortization and Depletion
|
-509.4990 | -310.8710 | -255.2400 | -217.0610 |
|
Operating Income/Expenses
|
-25,392.3270 | -11,003.3040 | -6,096.9870 | -6,108.2490 |
|
Total Operating Profit/Loss
|
-5,372.1200 | 462.9120 | 2,683.9230 | 3,038.2890 |
| Total Net Finance Income/Expense
|
-2,870.9600 | -2,261.2410 | -1,622.4610 | -1,674.9490 |
|
Other Income/Expense, Non-Operating
|
-140.3340 | -205.4230 | -69.7780 | -67.8370 |
|
Non-Operating Income/Expenses, Total
|
-3,011.2940 | -2,466.6640 | -1,692.2390 | -1,742.7860 |
|
Pretax Income
|
-8,383.4140 | -2,003.7520 | 991.6840 | 1,295.5030 |
|
Provision for Income Tax
|
131.9550 | 131.9550 | 0 | -- |
|
Net Income from Continuing Operations
|
-8,252.6090 | -1,871.7970 | 991.6840 | 1,295.5030 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-8,252.6090 | -1,871.7970 | 991.6840 | 1,295.5030 |
|
Non-Controlling/Minority Interests
|
200.6070 | -- | -- | -- |
|
Net Income after Non-Controlling/Minority Interests
|
-8,052.0020 | -1,871.7970 | 991.6840 | 1,295.5030 |
|
Net Income Available to Common Stockholders
|
-8,052.0020 | -1,871.7970 | 991.6840 | 1,295.5030 |
|
Diluted Net Income Available to Common Stockholders
|
-8,052.0020 | -1,871.7970 | 991.6840 | 1,295.5030 |
| Basic EPS
|
-0.34 | -0.09 | 0.04 | 0.05 |
| Diluted EPS
|
-0.34 | -0.09 | 0.04 | 0.05 |
|
Basic Weighted Average Shares Outstanding
|
22,785.4440 | 20,509.3560 | 20,000 | 20,000 |
|
Diluted Weighted Average Shares Outstanding
|
22,785.4440 | 20,509.3560 | 20,000 | 20,000 |
| Income Statement, Supplemental
|
||||
|
EBIT
|
-5,512.4540 | 257.4890 | 2,614.1450 | 2,970.4520 |
|
EBITDA
|
-5,002.9550 | 568.3600 | 2,869.3850 | 3,187.5130 |
|
Normalized EBITDA
|
-5,002.9550 | 436.9600 | 1,246.9240 | 3,187.5130 |
|
Normalized Income
|
-8,252.6090 | -218.9319 | 991.6840 | 1,295.5030 |
|
Total Unusual Items
|
0 | 1,800.8990 | 0 | 0 |
|
Total Unusual Items Excluding Goodwill
|
0 | 1,800.8990 | 0 | 0 |
|
Tax Effect of Unusual Items
|
0 | 148.0339 | 0 | 0 |
12/31/2023 - 11/13/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade